Thus, the combined loss of PTEN and p53 in prostate cancer upregulated HK2 through an increase in mRNA translation (induced by Pten deletion) and an increase in mRNA stability (mediated by Tp53 deletion) [88]. The gene discussed is TP53; the disease is Familial prostate cancer.